Subscribe To

Price Alert Latest News Economic Calendar News

CNC / Centene Corp (CNC) Q4 2022 Earnings Call Transcript

Centene Corp (NYSE:CNC ) Q4 2022 Earnings Conference Call February 7, 2023 8:30 AM ET Company Participants Sarah London - CEO & Director Jennifer Gilligan - SVP, IR Kenneth Fasola - President James Murray - EVP & COO Andrew Asher - EVP & CFO Conference Call Participants Joshua Raskin - Nephron Research Stephen Baxter - Wells Fargo Securities Justin Lake - Wolfe Research A.J. Rice - Crédit Suisse Scott Fidel - Stephens Calvin Sternick - JPMorgan Chase & Co. Gary Taylor - Cowen and Company Steven Valiquette - Barclays Bank Kevin Fischbeck - Bank of America Merrill Lynch Michael Ha - Morgan Stanley George Hill - Deutsche Bank Nathan Rich - Goldman Sachs Group Operator Good day, and welcome to the Centene Fourth Quarter Earnings Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Centene

Corp

CNC

2022

Earnings

Call

Transcript

Stock

Posted: Feb 7 2023, 12:20

Author Name: Seeking Alpha

CNC News

By Zacks Investment Research
November 3, 2023

5 Low Price-to-Book Stocks to Buy in November

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), PVH Corp. (PVH), Centene

By Zacks Investment Research
November 2, 2023

Give Your Investments a Boost With These 4 Low P/CF Stocks

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), Hibbett (HIBB), PVH Corp.

By Zacks Investment Research
October 27, 2023

Should Value Investors Buy Centene (CNC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe

By Zacks Investment Research
October 24, 2023

Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised

Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.

By Zacks Investment Research
October 24, 2023

Centene (CNC) Beats Q3 Earnings and Revenue Estimates

Centene (CNC) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of

By Reuters
October 24, 2023

Centene's quarterly profit beats estimates

Centene Corp beat Wall Street estimates for third-quarter profit on Tuesday, helped by lower-than-feared medical costs.

By Zacks Investment Research
October 17, 2023

Can Centene's (CNC) Q3 Earnings Beat on Membership Growth?

Centene's (CNC) third-quarter results are likely to reflect higher premiums and lower cost of services.

By Zacks Investment Research
October 12, 2023

Centene (CNC) Eyes Membership Growth With 2024 Expansion Plans

Centene (CNC) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.